CNS Pharmaceuticals Q3 EPS $(0.24) Beats $(0.27) Estimate
Benzinga Newsdesk 2 days ago
NewsEarningsEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.27) by 11.11 percent. This is a 95.83 percent increase over losses of $(5.76) per share
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.27) by 11.11 percent. This is a 95.83 percent increase over losses of $(5.76) per share from the same period last year.
